{
    "2021-12-09": [
        [
            {
                "time": "",
                "original_text": "2022年医药行业策略报告：回本溯源 看好药品行业的长期投资机会",
                "features": {
                    "keywords": [
                        "医药行业",
                        "策略报告",
                        "长期投资机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "人民金融·创新药指数涨0.94% | 腾盛博药中和抗体更大市场在海外 正在研究用于预防新冠",
                "features": {
                    "keywords": [
                        "创新药指数",
                        "腾盛博药",
                        "中和抗体",
                        "新冠"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "“优等生”智飞生物缘何难获投资者“青睐”？两个现象需留意",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "投资者青睐",
                        "现象"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物市值缩水2000亿 从代理商到研发巨头距离有多远？",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "市值缩水",
                        "研发巨头"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}